Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-01-18

Clinical Trial Update: Tranexamic Acid in Gender Mastectomy [Phase 4]

View source ↗

Summary

Clinical trial of tranexamic acid in gender mastectomy (Phase 4) is withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Surgery | Phase 4 | Status: WITHDRAWN